Jason Gertz

Jason Gertz

Auto-generated profile, based on publicly available information

Jason Gertz

Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2012 in Genome Research
Verified
Journal Article
Open access
PDF file
SLStephen G. Landt
Stephen G. Landt
GMGeorgi Marinov
Georgi Marinov
AKAnshul Kundaje
Anshul Kundaje
PKPouya Kheradpour
Pouya Kheradpour
FPFlorencia Pauli
Florencia Pauli
MSMichael P Snyder
Michael P Snyder
Chromatin immunoprecipitation (ChIP) followed by high-throughput DNA sequencing (ChIP-seq) has become a valuable and widely used approach for mapping the genomic location of transcription-factor binding and histone modifications in living cells. Despite its widespread use, there are considerable differences in how these experiments are conducted, how the results are scored and evaluated for quality, and how the data and metadata are archived for public use. These practices affect the quality and utility of any global ChIP experiment. Through our experience in performing ChIP-seq experiments, the ENCODE and modENCODE consortia have developed a set of working standards and guidelines for ChIP experiments that are updated routinely. The current guidelines address antibody validation, experimental replication, sequencing depth, data and metadata reporting, and data quality assessment. We discuss how ChIP quality, assessed in these ways, affects different uses of ChIP-seq data. All data sets used in the analysis have been deposited for public viewing and downloading at the ENCODE (http://encodeproject.org/ENCODE/) and modENCODE (http://www.modencode.org/) portals.

5 September 2012 in Nature
Verified
Journal Article
Open access
PDF file
MGMark B. Gerstein
Mark B. Gerstein
AKAnshul Kundaje
Anshul Kundaje
MHManoj Hariharan
Manoj Hariharan
SLStephen G. Landt
Stephen G. Landt
KYKoon-Kiu Yan
Koon-Kiu Yan
MSMichael P Snyder
Michael P Snyder
Transcription factors bind in a combinatorial fashion to specify the on-and-off states of genes; the ensemble of these binding events forms a regulatory network, constituting the wiring diagram for a cell. To examine the principles of the human transcriptional regulatory network, we determined the genomic binding information of 119 transcription-related factors in over 450 distinct experiments. We found the combinatorial, co-association of transcription factors to be highly context specific: distinct combinations of factors bind at specific genomic locations. In particular, there are significant differences in the binding proximal and distal to genes. We organized all the transcription factor binding into a hierarchy and integrated it with other genomic information (for example, microRNA regulation), forming a dense meta-network. Factors at different levels have different properties; for instance, top-level transcription factors more strongly influence expression and middle-level ones co-regulate targets to mitigate information-flow bottlenecks. Moreover, these co-regulations give rise to many enriched network motifs (for example, noise-buffering feed-forward loops). Finally, more connected network components are under stronger selection and exhibit a greater degree of allele-specific activity (that is, differential binding to the two parental alleles). The regulatory information obtained in this study will be crucial for interpreting personal genome sequences and understanding basic principles of human biology and disease.

16 January 2013 in Genome Research
Verified
Journal Article
Open access
PDF file
KVKatherine E. Varley
Katherine E. Varley
JGJason Gertz
Jason Gertz
KBKevin M. Bowling
Kevin M. Bowling
SPStephanie L. Parker
Stephanie L. Parker
TRTimothy E. Reddy
Timothy E. Reddy
RMRichard M. Myers
Richard M. Myers
As studies of DNA methylation increase in scope, it has become evident that methylation has a complex relationship with gene expression, plays an important role in defining cell types, and is disrupted in many diseases. We describe large-scale single-base resolution DNA methylation profiling on a diverse collection of 82 human cell lines and tissues using reduced representation bisulfite sequencing (RRBS). Analysis integrating RNA-seq and ChIP-seq data illuminates the functional role of this dynamic mark. Loci that are hypermethylated across cancer types are enriched for sites bound by NANOG in embryonic stem cells, which supports and expands the model of a stem/progenitor cell signature in cancer. CpGs that are hypomethylated across cancer types are concentrated in megabase-scale domains that occur near the telomeres and centromeres of chromosomes, are depleted of genes, and are enriched for cancer-specific EZH2 binding and H3K27me3 (repressive chromatin). In noncancer samples, there are cell-type specific methylation signatures preserved in primary cell lines and tissues as well as methylation differences induced by cell culture. The relationship between methylation and expression is context-dependent, and we find that CpG-rich enhancers bound by EP300 in the bodies of expressed genes are unmethylated despite the dense gene-body methylation surrounding them. Non-CpG cytosine methylation occurs in human somatic tissue, is particularly prevalent in brain tissue, and is reproducible across many individuals. This study provides an atlas of DNA methylation across diverse and well-characterized samples and enables new discoveries about DNA methylation and its role in gene regulation and disease.

1 February 2017 in Cancer Cell
Verified
Journal Article
Closed access
GMGurkan Mollaoglu
Gurkan Mollaoglu
MGMatthew R. Guthrie
Matthew R. Guthrie
SBStefanie Böhm
Stefanie Böhm
JBJohannes Brägelmann
Johannes Brägelmann
ICIsmail Can
Ismail Can
TOTrudy G. Oliver
Trudy G. Oliver

5 September 2012 in Genome Research
Verified
Journal Article
Open access
PDF file
HWHao Wang
Hao Wang
MMMatthew T. Maurano
Matthew T. Maurano
HQHongzhu Qu
Hongzhu Qu
KVKatherine E. Varley
Katherine E. Varley
JGJason Gertz
Jason Gertz
JSJohn A. Stamatoyannopoulos
John A. Stamatoyannopoulos
CTCF is a ubiquitously expressed regulator of fundamental genomic processes including transcription, intra- and interchromosomal interactions, and chromatin structure. Because of its critical role in genome function, CTCF binding patterns have long been assumed to be largely invariant across different cellular environments. Here we analyze genome-wide occupancy patterns of CTCF by ChIP-seq in 19 diverse human cell types, including normal primary cells and immortal lines. We observed highly reproducible yet surprisingly plastic genomic binding landscapes, indicative of strong cell-selective regulation of CTCF occupancy. Comparison with massively parallel bisulfite sequencing data indicates that 41% of variable CTCF binding is linked to differential DNA methylation, concentrated at two critical positions within the CTCF recognition sequence. Unexpectedly, CTCF binding patterns were markedly different in normal versus immortal cells, with the latter showing widespread disruption of CTCF binding associated with increased methylation. Strikingly, this disruption is accompanied by up-regulation of CTCF expression, with the result that both normal and immortal cells maintain the same average number of CTCF occupancy sites genome-wide. These results reveal a tight linkage between DNA methylation and the global occupancy patterns of a major sequence-specific regulatory factor.

3 December 2013 in Genome Research
Verified
Journal Article
Open access
PDF file
GMGeorgi K. Marinov
Georgi K. Marinov
BWBrian A. Williams
Brian A. Williams
KMKen McCue
Ken McCue
GSGary P. Schroth
Gary P. Schroth
JGJason Gertz
Jason Gertz
BWBarbara J. Wold
Barbara J. Wold
Single-cell RNA-seq mammalian transcriptome studies are at an early stage in uncovering cell-to-cell variation in gene expression, transcript processing and editing, and regulatory module activity. Despite great progress recently, substantial challenges remain, including discriminating biological variation from technical noise. Here we apply the SMART-seq single-cell RNA-seq protocol to study the reference lymphoblastoid cell line GM12878. By using spike-in quantification standards, we estimate the absolute number of RNA molecules per cell for each gene and find significant variation in total mRNA content: between 50,000 and 300,000 transcripts per cell. We directly measure technical stochasticity by a pool/split design and find that there are significant differences in expression between individual cells, over and above technical variation. Specific gene coexpression modules were preferentially expressed in subsets of individual cells, including one enriched for mRNA processing and splicing factors. We assess cell-to-cell variation in alternative splicing and allelic bias and report evidence of significant differences in splice site usage that exceed splice variation in the pool/split comparison. Finally, we show that transcriptomes from small pools of 30–100 cells approach the information content and reproducibility of contemporary RNA-seq from large amounts of input material. Together, our results define an experimental and computational path forward for analyzing gene expression in rare cell types and cell states.